The $10 billion biotech Moderna evolved a possible coronavirus vaccine in report time, zooming previous Big Pharma competition. The corporate’s CEO Stephane Bancel sat down with Business Insider to talk about the generation platform that drove its velocity, and the way the corporate hopes to pioneer a brand new method